Research Brief – (CBD) A Cross-Sectional Study of Cannabidiol Users

Corroon J, Phillips JA. A Cross-Sectional Study of Cannabidiol Users. Cannabis and Cannabinoid Research. 2018;3(1):152-161. doi:10.1089/can.2018.0006

Cannabidiol (CBD) has a broad therapeutic effect in clinical and preclinical research studies. Today, there is a wide range of available CBD products which can be purchased over-the-counter, and online. Even though the demand for CBD continues to grow at a steady pace, the research data on why there is such a demand is limited. 

How and Why CBD is Being Used

This article is aimed at discovering who uses CBD, and how and why they used the phytocannibinoid. An online questionnaire was sent anonymously from October of 2017 to January, 2018. Social media was the platform used to recruit study participants. 

The study discovered that:

  • Nearly 62% of CBD users reportedly took CBD for medical conditions.
  • The top 3 most prevalent conditions for CBD users included anxiety, pain, and depression.
  • 36% of the Study participants reported that CBD alone treated their medical condition (s). 
  • 4.3% reported that CBD was not completely effective in treating their medical condition.
  • One out of every three CBD users reported minor adverse effects from CBD use (dry mouth, sleepy/groggy, euphoria, hunger, red eyes, other).

The study concluded that participants used CBD for multiple medical conditions, including maladies such as anxiety, depression, pain, and sleep disorders. The study authors wrote, “These data provide a compelling rationale for further research to better understand the therapeutic potential of CBD.”

Link to the article:
Contributing Author: Sherry Christiansen

Shopping Cart

Product Enquiry

Bulk Order Wholesale Pricing
Scroll to Top